1. Cost-effectiveness of palonosetron and dexamethasone-based triple and quadruple regimens in preventing highly emetogenic chemotherapy-induced nausea and vomiting. (3rd April 2022) Authors: Halloush, Shiraz; Alhifany, Abdullah A.; Alkhatib, Nimer S.; Al Bawab, Abdel Qader; AL-Qawasmeh, Batool; Al Shawakri, Esra'a; Koeller, Jim Journal: Current medical research and opinion Issue: Volume 38:Number 4(2022) Page Start: 571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗